de Morais Filho, Valdemar Mendes, Gisele Wevely de Souza Melo, Janainna Rocha Batista Oliveira, Cleonice Lucia Martins, Vania do Socorro Rodrigues Vasconcelos, Arinea Avelar de Avelar, Julio Gladston Ribeiro Santos, et al. “INDISCRIMINATE USE OF GLP-1 ANALOGUES, SUCH AS SEMAGLUTIDE (OZEMPIC®), FOR AESTHETIC PURPOSES AND MULTIDISCIPLINARY ACTION IN CARE AND RISK PREVENTION”. Editora Impacto Científico (October 20, 2025): 342–356. Accessed June 23, 2026. https://periodicos.newsciencepubl.com/editoraimpacto/article/view/9073.